Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ConnectOne Bancorp, Inc.
14.8% sales growth and 8.25% return on equity
ConnectOne Bancorp, Inc. operates as the bank holding company for ConnectOne Bank, a state chartered bank that provides various commercial banking products and services.
ConnectOne Bancorp, Inc. sales growth this year is anticipated to be 29.7% and a negative 0.5% for next year.
Year-on-year quarterly revenue growth grew by 20.6%, now sitting on 200.76M for the twelve trailing months.
ConnectOne Bancorp, Inc.'s sales growth for the next quarter is 14.8%. The company's growth estimates for the current quarter and the next is a negative 11.5% and 88.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.25%.
ConnectOne Bancorp, Inc.'s Stock Top and Bottom Yearly Value
ConnectOne Bancorp, Inc.'s stock is valued at $18.93 at 06:43 EST, way under its 52-week high of $26.50 and way higher than its 52-week low of $8.86.
ConnectOne Bancorp, Inc.'s Moving Average
ConnectOne Bancorp, Inc.'s value is way above its 50-day moving average of $16.85 and way above its 200-day moving average of $15.29.
2. Vipshop Holdings Limited
45.4% sales growth and 20.62% return on equity
Vipshop Holdings Limited operates as an online discount retailer for various brands in the People's Republic of China.
Vipshop Holdings Limited sales growth this year is anticipated to be 15.6% and 17.1% for next year.
Year-on-year quarterly revenue growth grew by 18.2%, now sitting on N/A for the twelve trailing months.
Vipshop Holdings Limited's sales growth for the next quarter is 45.4%. The company's growth estimates for the ongoing quarter and the next is 20% and 61.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.62%.
Vipshop Holdings Limited's Stock Top and Bottom Yearly Value
Vipshop Holdings Limited's stock is valued at $25.08 at 06:43 EST, under its 52-week high of $26.07 and way higher than its 52-week low of $11.53.
Vipshop Holdings Limited's Moving Average
Vipshop Holdings Limited's value is way higher than its 50-day moving average of $21.87 and way higher than its 200-day moving average of $19.57.
3. Thor Industries, Inc.
17.7% sales growth and 9.97% return on equity
Thor Industries, Inc. designs, manufactures, and sells recreational vehicles (RVs), and related parts and accessories in the United States, Canada, and Europe.
Thor Industries, Inc. sales growth this year is expected to be 21.8% and 4.4% for next year.
Year-on-year quarterly revenue growth grew by 0.5%, now sitting on 8.17B for the twelve trailing months.
Thor Industries, Inc.'s sales growth for the next quarter is 17.7%. The company's growth estimates for the present quarter and the next is 69.6% and 92.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.97%.
Thor Industries, Inc.'s Stock Top and Bottom Yearly Value
Thor Industries, Inc.'s stock is valued at $95.85 at 06:43 EST, way under its 52-week high of $121.33 and way above its 52-week low of $32.30.
Thor Industries, Inc.'s Moving Average
Thor Industries, Inc.'s worth is above its 50-day moving average of $90.79 and under its 200-day moving average of $99.21.
4. First Foundation Inc.
14.2% sales growth and 12.04% return on equity
First Foundation Inc., through its subsidiaries, provides financial services to individuals, businesses, and other organizations in the United States.
First Foundation Inc. sales growth this year is anticipated to be 17.5% and 2.4% for next year.
Year-on-year quarterly revenue growth grew by 29.4%, now sitting on 234.63M for the twelve trailing months.
First Foundation Inc.'s sales growth for the next quarter is 14.2%. The company's growth estimates for the current quarter and the next is 29.4% and 41.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.04%.
First Foundation Inc.'s Stock Top and Bottom Yearly Value
First Foundation Inc.'s stock is valued at $19.26 at 06:43 EST, below its 52-week high of $20.24 and way higher than its 52-week low of $8.01.
First Foundation Inc.'s Moving Average
First Foundation Inc.'s worth is way above its 50-day moving average of $16.54 and way above its 200-day moving average of $15.43.
5. CNB Financial Corporation
21.4% sales growth and 9.91% return on equity
CNB Financial Corporation operates as the bank holding company for CNB Bank that provides a range of banking products and services for individual, business, governmental, and institutional customers.
CNB Financial Corporation sales growth this year is anticipated to be 14.5% and 6.9% for next year.
Year-on-year quarterly revenue growth grew by 12%, now sitting on 138.31M for the twelve trailing months.
CNB Financial Corporation's sales growth for the next quarter is 21.4%. The company's growth estimates for the current quarter and the next is a negative 15.9% and 3.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.91%.
CNB Financial Corporation's Stock Top and Bottom Yearly Value
CNB Financial Corporation's stock is valued at $20.21 at 06:43 EST, way under its 52-week high of $33.68 and way above its 52-week low of $13.25.
CNB Financial Corporation's Moving Average
CNB Financial Corporation's value is above its 50-day moving average of $19.04 and way higher than its 200-day moving average of $17.31.
Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
